Compare TITN & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TITN | BWAY |
|---|---|---|
| Founded | 1980 | 2003 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 552.6M | 547.7M |
| IPO Year | 2007 | 2011 |
| Metric | TITN | BWAY |
|---|---|---|
| Price | $23.16 | $12.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $25.25 | $19.27 |
| AVG Volume (30 Days) | ★ 174.0K | 89.0K |
| Earning Date | 11-24-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,427,107,000.00 | N/A |
| Revenue This Year | N/A | $32.42 |
| Revenue Next Year | $3.29 | $23.40 |
| P/E Ratio | ★ N/A | $81.98 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.21 | $11.77 |
| 52 Week High | $26.90 | $26.63 |
| Indicator | TITN | BWAY |
|---|---|---|
| Relative Strength Index (RSI) | 51.55 | 31.45 |
| Support Level | $22.52 | $11.90 |
| Resistance Level | $25.00 | $14.83 |
| Average True Range (ATR) | 0.89 | 0.55 |
| MACD | -0.28 | -0.02 |
| Stochastic Oscillator | 17.87 | 0.61 |
Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.